KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Clinical trial NCT06400303 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06400303
Sponsor: Kyverna Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis Systemic Sclerosis - Diffuse Cutaneous Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria

Start date: 2024-08-06
Primary completion: 2026-03-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.